Mammea A/BA demonstrates significant efficacy in inhibiting Trypanosoma cruzi (T. cruzi), through mechanisms such as mitochondrial dysfunction, increased production of reactive oxygen species (ROS), and DNA fragmentation, alongside elevating acidic vacuole numbers. This compound is capable of inducing apoptosis, autophagy, and necrosis, making it a valuable research tool for Chagas disease.